Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 3 1

Status

Completed 6Terminated 4Unknown 1Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other 3Thoracic 1

Conditions

Neoplasms 2Constipation 2Pain 1Opioid-Induced Constipation 1Carcinoma, Non-Small-Cell Lung 1Cancer Pain 1

Interventions

Cyclophosphamide 391Carboplatin 344Gemcitabine 332pembrolizumab 331Cisplatin 328Paclitaxel 298Radiotherapy 297Docetaxel 287Bevacizumab 253Rituximab 234Capecitabine 224Nivolumab 222Dexamethasone 206Fluorouracil 190fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 134Cetuximab 130fludarabine phosphate 129Bortezomib 129Lenalidomide 126Filgrastim 120Erlotinib Hydrochloride 120Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × naloxegol × Clear all
NCT03087708 2025-07-17

Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Terminated
50 enrolled 24 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02745353 2019-12-09

Naloxegol in Cancer Opioid-Induced Constipation

University of California, San Diego

Phase 2 Terminated
7 enrolled 9 charts
Other

Constipation, Neoplasms

NCT02839889 2019-03-05

Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)

Hospice of Henderson County, Inc.

Phase 4 Terminated
12 enrolled 33 charts
Other

Constipation, Neoplasms, Pain

NCT01384292 2015-06-01

Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain

AstraZeneca

Phase 3 Terminated
14 enrolled 7 charts
Other

Cancer Pain, Opioid-Induced Constipation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡